These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
325 related items for PubMed ID: 8381725
1. Role of platelet-activating factor in hypotension and platelet activation induced by infusion of thrombolytic agents in rabbits. Montrucchio G, Alloatti G, Mariano F, Lupia E, Lucchina PG, Musso E, Emanuelli G, Camussi G. Circ Res; 1993 Mar; 72(3):658-70. PubMed ID: 8381725 [Abstract] [Full Text] [Related]
2. Streptokinase induces intravascular release of platelet-activating factor in patients with acute myocardial infarction and stimulates its synthesis by cultured human endothelial cells. Montrucchio G, Bergerone S, Bussolino F, Alloatti G, Silvestro L, Lupia E, Cravetto A, Di Leo M, Emanuelli G, Camussi G. Circulation; 1993 Oct; 88(4 Pt 1):1476-83. PubMed ID: 8403295 [Abstract] [Full Text] [Related]
3. Pharmacological actions of Y-24180, a new specific antagonist of platelet activating factor (PAF): II. Interactions with PAF and benzodiazepine receptors. Takehara S, Mikashima H, Muramoto Y, Terasawa M, Setoguchi M, Tahara T. Prostaglandins; 1990 Dec; 40(6):571-83. PubMed ID: 1965554 [Abstract] [Full Text] [Related]
4. Biochemical and pharmacological activities of SR 27417, a highly potent, long-acting platelet-activating factor receptor antagonist. Herbert JM, Bernat A, Valette G, Gigo V, Lale A, LaPlace MC, Lespy L, Savi P, Maffrand JP, Le Fur G. J Pharmacol Exp Ther; 1991 Oct; 259(1):44-51. PubMed ID: 1656029 [Abstract] [Full Text] [Related]
7. Effects of WEB 2086, an antagonist to the receptor for platelet-activating factor (PAF), on PAF-induced responses in the horse. Foster AP, Lees P, Andrews MJ, Cunningham FM. Equine Vet J; 1992 May; 24(3):203-7. PubMed ID: 1318830 [Abstract] [Full Text] [Related]
8. Tissue-type plasminogen activator and streptokinase induce platelet hyperaggregability in the rabbit. Ohlstein EH, Storer B, Fujita T, Shebuski RJ. Thromb Res; 1987 May 15; 46(4):575-85. PubMed ID: 3112993 [Abstract] [Full Text] [Related]
13. Temporal effects of thrombolytic agents on platelet function in vivo and their modulation by prostaglandins. Rudd MA, George D, Amarante P, Vaughan DE, Loscalzo J. Circ Res; 1990 Nov 15; 67(5):1175-81. PubMed ID: 2146037 [Abstract] [Full Text] [Related]
15. Biochemical and pharmacological properties of SR 27388, a dual antioxidant and PAF receptor antagonist. Herbert JM, Fraisse L, Bachy A, Valette G, Savi P, Laplace MC, Lassalle J, Roche B, Lale A, Keane PE. J Lipid Mediat; 1993 Aug 15; 8(1):31-51. PubMed ID: 8257776 [Abstract] [Full Text] [Related]
16. Continuous binding of the PAF molecule to its receptor is necessary for the long-term aggregation of platelets. Suzuki M, Sugatani J, Ino M, Shimura M, Akiyama M, Yamazaki R, Suzuki Y, Miwa M. Am J Physiol; 1998 Jan 15; 274(1):C47-57. PubMed ID: 9458712 [Abstract] [Full Text] [Related]
18. In vitro effect of plasmin on human platelet function in plasma. Inhibition of aggregation caused by fibrinogenolysis. Gouin I, Lecompte T, Morel MC, Lebrazi J, Modderman PW, Kaplan C, Samama MM. Circulation; 1992 Mar 15; 85(3):935-41. PubMed ID: 1531623 [Abstract] [Full Text] [Related]
19. Interaction of the Paf antagonist WEB 2086 and its hetrazepine analogues with human platelets and endothelial cells. Korth R, Hirafuji M, Keraly CL, Delautier D, Bidault J, Benveniste J. Br J Pharmacol; 1989 Oct 15; 98(2):653-61. PubMed ID: 2555017 [Abstract] [Full Text] [Related]
20. CIS-19, a novel platelet activating factor receptor antagonist: in vitro and in vivo studies. Ko FN, Yu SM, Chen IS, Ishii H, Chang YL, Huang TF, Teng CM. Biochim Biophys Acta; 1993 Jan 17; 1175(2):225-31. PubMed ID: 8380343 [Abstract] [Full Text] [Related] Page: [Next] [New Search]